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Abstract
Human laminin receptor acts as both a component of the 40S ribosomal subunit to mediate cellular translation and as a cell
surface receptor that interacts with components of the extracellular matrix. Due to its role as the cell surface receptor for
several viruses and its overexpression in several types of cancer, laminin receptor is a pathologically significant protein.
Previous studies have determined that ribosomes are associated with components of the cytoskeleton, however the specific
ribosomal component(s) responsible has not been determined. Our studies show that laminin receptor binds directly to
tubulin. Through the use of siRNA and cytoskeletal inhibitors we demonstrate that laminin receptor acts as a tethering
protein, holding the ribosome to tubulin, which is integral to cellular translation. Our studies also show that laminin
receptor is capable of binding directly to actin. Through the use of siRNA and cytoskeletal inhibitors we have shown that
this laminin receptor-actin interaction is critical for cell migration. These data indicate that interactions between laminin
receptor and the cytoskeleton are vital in mediating two processes that are intimately linked to cancer, cellular translation
and migration.
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Introduction
The 37/67 kDa laminin receptor (LamR), originally discovered
as a 67 kDa cell surface receptor for laminin-1 in the extracellular
matrix (ECM) [1,2,3], has a dual function as a component of the
translational machinery and a cell surface receptor. The
relationship between the 37 kDa and 67 kDa forms of LamR is
not completely understood. The 67 kDa form of LamR is
predicted to be a dimer, but whether LamR forms a homo-dimer
[4] or hetero-dimer [5,6] has yet to be resolved. Amino acid
composition analysis indicates that LamR exists as a homo-dimer
at the cell surface [4]. Immunoblotting of detergent extracts
indicates that LamR forms a hetero-dimer with galectin3 [5].
Additionally, post translational modifications have been suggested
to stabilize the 67 kDa form and may be required for LamR
association with the cell membrane [4,5]. At the cell surface,
LamR also acts as the receptor for several viruses including Sindbis
virus [7], Venezuelan equine encephalitis virus [8] and Dengue
virus [9,10] as well as for prion proteins [11]. LamR, which is
upregulated on a number of human cancers [12,13,14,15,16],
plays a role in migration, tumor invasion and metastasis [17,18]
through interactions with laminin-1. Intracellularly, LamR, also
known as p40 ribosomal protein and RPSA, acts as an integral
component of the 40S ribosomal subunit [19] and is involved in
cellular translation and proliferation [20]. LamR is highly
conserved across species from bacteria to humans [21]. The
LamR orthologs in yeast have been shown to be polysome-
associated [22] and involved in maturation of the 40S ribosome,
specifically processing of the 20S to 18S rRNA [23]. In addition,
LamR plays a role in maintaining cell viability in yeast [23] and in
a number of human cells [20,23,24,25,26].
Previous studies have also implicated 67 kDa LamR in binding
interactions with actin at the cell membrane. A 70 kDa cell-surface
protein, originally called connectin, was found to bind both
laminin and actin in vitro [27]. It was also found that clustering of
laminin in the ECM results in LamR clustering and subsequent
actin remodeling [28]. Further, a 69 kDa laminin-binding protein
was found to interact with microfilaments to mediate cell
attachment and migration [29]. These data indicate that LamR
interactions with the cytoskeleton might play a role in cell motility.
The cytoskeleton, an elaborate network of proteins, is
responsible for providing structure and shape to the cell and
manipulating the cell membrane to induce cell motility. This
network is comprised of three main types of proteins: microfila-
ments comprised of helical assemblies of actin, microtubules
comprised of alpha and beta tubulin dimers and intermediate
filaments comprised of a number of different proteins, depending
on cell type. The cytoskeleton is also associated with many cellular
components such as the nucleus, the cell membrane, vesicles and
other macromolecules [30,31,32,33]. This protein meshwork acts
as a highway connecting different points of the cell and utilizing
molecular motors powered by filament assembly forces to
transport proteins and organelles across the cell’s span
[34,35,36]. In response to migration-inducing stimuli, actin
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lamellipodia and filapodia protrusions [37]. These protrusions,
which are stabilized by transmembrane receptors interacting with
the ECM, enable the cell to crawl by the use of these adhesions at
the leading edge [38]. In addition, the cytoskeleton plays a role in
cellular translation. It was originally thought that translation of
select transcripts occurred at the cytoskeleton [39], however new
evidence indicates that a significant portion of translation may
occur bound to the cytoskeleton [40]. Immunofluorescence
staining and electron microscopy indicates that polysomes co-
localize with cytoskeletal components [41,42,43,44,45]. Detergent
treatment of cells, which removes polysomes bound to the
endoplasmic reticulum, indicates that polyribosomes bind to the
cytoskeleton [42,46,47]. Treatment with agents that depolymerize
actin or induce improper organization causes the release of
polysomes from the cytoskeleton and inhibits protein synthesis
[42,48,49,50].
This study examines LamR interactions with the cytoskeleton.
Utilizing microscopy we have shown that the interaction between
LamR and F-actin is related to LamR functions at the cell
membrane. Microscopy revealed actin reorganization, formation
of lamellipodia, and LamR localization at the leading edge
following cell plating on laminin. Ablation of LamR expression
inhibited cell migration comparable to the effects of inhibiting
actin filament formation. Further, 37 kDa LamR was found to
directly bind actin in an in vitro binding assay. These data indicate
that the interaction between actin and LamR mediates cell
motility.
Through microscopy we have found that LamR and S6,
another 40S ribosomal component co-localize with a-tubulin. Co-
localization is lost with treatment that disrupts microtubule
dynamics. The direct interaction of LamR with tubulin, coupled
with the dissociation of S6 from the cytoskeleton following
treatment with taxol or siLamR, suggests that LamR may act as
a tether to bind the translation complex to the cytoskeleton. This
study demonstrates that interactions between LamR and compo-
nents of the cytoskeleton, actin and tubulin, play a role in
mediating cell motility and translation.
Results
LamR Localization
LamR is an integral ribosomal component, which is required for
protein translation [19,20]. Through the use of immunofluores-
cence, we confirmed co-localization of LamR with S6, used
throughout this study as a marker for the 40S ribosomal subunit
(Figure 1A). In order to study LamR interactions with cytoskeletal
components, we examined the cellular localization of a-tubulin in
relation to LamR. These data revealed that LamR also co-
localizes with a-tubulin (Figure 1B), which indicates that LamR in
complex with the ribosome may be associated with tubulin.
Characterization of the LamR-a-Tubulin Interaction
To study interactions between the ribosome and a-tubulin,
siRNA was employed to ablate expression of either LamR or S6
ribosomal protein. LamR-specific siRNA successfully ablates
expression of both the 37 and 67 kDa forms of the protein.
Successful knockdown of LamR and S6 was confirmed by western
blot analysis (Figure S1A and B). Although knockdown of S6
expression was less efficient than LamR,
35S labeling confirmed
inhibition of protein synthesis (Figure S1C). siGLO, a RISC free
fluorescently conjugated control oligo, coupled with FACS analysis
was utilized to assess transfection efficiency (Figure S1D). siLamR
and siS6 treated samples were subjected to immunofluorescence to
study the effect knockdown had on association with a-tubulin. In
cells where expression of LamR had been ablated, cytoplasmic S6
staining became diffuse, indicating that S6 was no longer
associated with a-tubulin (Figure 2A, middle panels). Additionally,
siLamR induced accumulation of S6 in the nucleus. LamR plays a
role in ribosome maturation [23], which could be inhibited in
siLamR treated cells. Since some ribosomal proteins have been
shown to bind to pre-ribosomes in the nucleus [51], loss of
ribosome maturation may cause these ribosomal proteins to
accumulate in the nucleus. This may account for the accumulation
of S6 in the nucleus in siLamR treated cells. In cells where
expression of S6 had been ablated, no change in LamR’s
cytoplasmic localization was observed, indicating that S6 is not
required for LamR association with a-tubulin (Figure 2A, bottom
panels). Treatment with siS6 did induce the accumulation of
LamR in the perinuclear region possibly near the microtubule
organizing center, which could be the result of S6-induced cell
cycle arrest. Knockdown of either LamR or S6 had no effect on
cytoplasmic a-tubulin localization (Figure 2B), however siLamR
treatment did result in the accumulation of a-tubulin in the
nucleus. Tubulin shuttles between the nucleus and cytoplasm [52]
and the cell cycle arrest induced by siRNA treatment could induce
its accumulation in the nucleus. These data indicate that LamR is
required for components of the 40S ribosomal subunit to co-
localize with a-tubulin.
Translation and the Cytoskeleton
Our data demonstrating the co-localization of components of
the 40S ribosome with a-tubulin indicates that some cellular
translation occurs at the cytoskeleton (Figure 1). To assess the
requirement of different components of the cytoskeleton for
cellular translation cells were treated with either cytochalasin B
(CB), which blocks monomer addition to actin filaments, or taxol,
which stabilizes microtubules and inhibits tubulin dynamics.
Treatment with CB resulted in loss of actin filament structure,
but had no effect on LamR or S6 localization (Figure 3A, middle
panels). While CB treatment had no effect on the a-tubulin
localization, taxol treatment resulted in an alteration of tubulin
structure (Figure 3B). The alteration in tubulin structure was likely
the result of a long incubation with taxol and not a loss of cell
viability, which was monitored in parallel. Treatment with taxol
also had a dramatic effect on both LamR and S6 localization,
causing both proteins to adopt a diffuse staining pattern (Figure 3A,
bottom panels).
The association between a-tubulin and 40S ribosomal compo-
nents S6 and LamR indicates that this interaction is related to
cellular translation. To further characterize the relationship
between tubulin and protein synthesis, cells were treated with
either CB or taxol and subjected to
35S labeling. Interestingly,
there was no change in protein synthesis in cells treated with CB
(Figure 3C). However, in cells treated with taxol, new protein
synthesis was significantly decreased (Figure 3C). These data
indicate that tubulin plays a critical role in mediating cellular
translation.
Characterization of the LamR-Actin Interaction
LamR interactions with tubulin appear to mediate translation
and are concentrated within the intracellular environment
(Figures 1–3). Interactions between LamR and actin appear to
affect extracellular functions. Under normal cell culture condi-
tions, LamR did not co-localize with F-actin at the cell surface
(Figure 4A). Plating cells on laminin coated chamber slides
induced a change in both cell morphology and LamR localization
(Figure 4B, top panels). The presence of laminin on the culture
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formation of lamellipodia with LamR concentrated at the terminal
ends (Figure 4B, top panels). Cellular fractionation coupled with
western blotting illustrated that there was no change in LamR
localization or concentration when cells were cultured on laminin
(Figure 4C), suggesting that the altered immunofluorescence
pattern resulted from a redistribution of LamR within the cellular
compartments. The additional band in the cytoplasmic fraction
likely represents LamR prior to post-translational modification,
which is important for membrane localization.
To study the formation of lamellipodia structures, cells were
treated with CB or LamR-specific siRNA to prevent formation of
actin filaments and translation of LamR, respectively. Treatment
with CB resulted in a loss of lamellipodia (Figure 4B, middle
panels). Ablation of LamR expression did not inhibit lamellipodia
formation (Figure 4B, bottom panels). Treatment with siLamR or
CB indicates that lamellipodia formation is dependent on a
functional actin structure rather than LamR.
The formation of lamellipodia is indicative of cell migration
[53]. To determine if both of these proteins are required for cell
migration, cells were either treated with CB or transfected with
siLamR and their ability to migrate to either purified laminin or
10% fetal calf serum (FCS) was assessed. Following either
treatment migration was reduced by 80% (Figure 4D). To confirm
that LamR expression and not inhibition of translation or cell
cycle arrest was responsible for the migration inhibition, cells were
treated with cycloheximide (CHX) or serum starved, respectively.
The efficacy of CHX treatment or serum starvation was confirmed
by
35S labeling and propidium iodide staining respectively (Figure
S2). Both CHX treatment and G1 phase cell cycle arrest had no
effect on cell migration indicating that the reduction in migration
was specific to the loss of LamR expression. These data indicate
that both LamR and actin play an important role in cell migration.
LamR Binds to Components of the Cytoskeleton
Immunofluorescence data indicate that LamR interacts with
tubulin (Figures 1–3) and both immunofluorescence and migration
data (Figure 4) demonstrate that LamR interacts with actin. To
determine whether LamR- cytoskeleton interactions are direct
binding events, we utilized purified recombinant LamR in a
binding enzyme-linked immunosorbent assay (ELISA) to measure
binding activity in vitro. Either tubulin or actin was immobilized on
an ELISA plate and LamR binding activity was assessed (Figure 5A
and B). A bacterial ortholog of LamR, A. fulgidus S2p ribosomal
protein (RPS2), was used as a negative control. LamR exhibits
specific binding to both tubulin and actin compared with A. fulgidus
S2p. LamR binding affinity was in the low micromolar range,
which suggests that interactions between LamR and both tubulin
and actin are of high affinity.
This study demonstrates that interactions between LamR and
tubulin or actin mediate both intracellular and extracellular
functions. Together these data indicate that LamR directly interacts
with components of the cytoskeleton and that these interactions are
important for mediating cellular translation and migration.
Discussion
LamR plays a role in intracellular functions, such as translation,
through its role as a component of the 40S ribosome [19,20] and
extracellular functions, such as cell migration and adhesion,
Figure 1. The S6 ribosomal protein and a-tubulin co-localize with LamR. (A) Immunofluorescence of fixed NIH 3T3 cells stained for LamR
(H141) (left), S6 (middle) and a merged image (right) illustrate co-localization of S6 with LamR. (B) Immunofluorescence of a fixed specimen stained
for LamR (H141) (left), a-tubulin (middle) and the merged image (right) indicate the co-localization of LamR with a-tubulin. Scale bars in A and B
represent 10 mm.
doi:10.1371/journal.pone.0015895.g001
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interactions between LamR and the cytoskeleton, specifically
actin, were thought to be exclusively related to cell motility and
attachment [29]. In addition, cytoskeletal interactions with the
ribosome have been shown, although the role of LamR has not
been previously elucidated. The studies presented here demon-
strate the direct, high affinity interaction between LamR and both
actin and tubulin. These data also suggest that LamR interactions
with tubulin are vital to LamR ribosomal functions, specifically
protein translation.
Co-localization of ribosomes with cytoskeletal components has
been verified by electron microscopy [54] and cell fractionation
studies [42]. Previous studies have implicated actin [41],
intermediate filaments [43] and tubulin [45,55] as the cytoskeletal
Figure 2. LamR tethers the ribosome to the cytoskeleton. (A and B) Immunofluorescence following knockdown of either LamR or S6. (A)
Microscopy image of samples stained for LamR (H141) (left), S6 (middle) or a merged overlay (right). Knockdown of LamR results in a change of the S6
localization from cytoskeleton-associated to diffuse. Knockdown of S6 has minimal effect on LamR localization, indicating that LamR tethers S6 to the
cytoskeleton. (B) Immunofluorescence of samples stained for LamR (H141) (left), a-tubulin (middle) or merged images (right). Microscopy indicates
that a-tubulin localization remains unaffected by knockdown of either protein. Scale bars in A and B represent 10 mm.
doi:10.1371/journal.pone.0015895.g002
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proteomics study aimed at finding microtubule binding proteins in
Arabidopsis identified LamR (ribosomal protein S2) [55]. Our study
indicates an interaction between LamR and tubulin in mammalian
cells, and also provides functional insight into this interaction. Our
microscopy studies, showed that LamR and a-tubulin co-localize.
Ablation of LamR and S6 expression demonstrated that LamR,
but not S6 was critical for interactions between a-tubulin and the
ribosome. In vitro binding assays verified that LamR specifically
binds tubulin with micromolar affinity. Together, these data
Figure 3. The cytoskeleton is important for translation. (A) Treatment of cells with agents to disrupt normal dynamics of the cytoskeleton
induces changes in LamR localization. NIH 3T3 cells treated with either CB to disrupt the actin filaments or, taxol to block tubulin dynamics were
subjected to immunofluorescence. Samples were stained for LamR (H141) (left) or S6 (middle) with the merged image. While treatment with CB had
no effect, taxol treatment produced a diffuse staining pattern for both LamR and S6, indicating that these proteins dissociated from the cytoskeleton.
(B) Samples treated similarly to panel A, were stained with LamR (H141) (left) or a-tubulin (middle) and overlaid image. In A and B panels showing F-
actin staining (right) were included as confirmation that the CB treatment was successful. Scale bars in A and B represent 10 mm. (C)
35S labeling of
cells following treatment with either CB or taxol. Protein synthesis was inhibited in taxol treated samples, however CB treatment had no effect.
doi:10.1371/journal.pone.0015895.g003
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PLoS ONE | www.plosone.org 5 January 2011 | Volume 6 | Issue 1 | e15895Figure 4. Characterization of the interaction between LamR and F-actin. (A) Immunofluorescence of NIH 3T3 cells stained for LamR (F18)
(left) or F-Actin (middle) and merged (right). (B) Plating cells on laminin-coated plates induces lamellipodia formation and LamR localizes to the
terminal ends of the actin fibers. Mock treated NIH 3T3 cells (top), cells treated with CB (middle) or cells transfected with siLamR (bottom) were plated
on laminin coated chamber slides. Cells were processed for immunofluorescence, staining for LamR (F18) (left) or F-actin (middle) and merged (right).
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the ribosome to the cytoskeleton.
Translation at the cytoskeleton was originally believed to be
responsible for the targeted protein synthesis of a small number of
mRNAs [39]. Evidence is now supporting the concept that a large
proportion of cellular translation takes place at the cytoskeleton
[40]. Through the use of CB and taxol, under conditions where
greater than 80% of cells are viable, we were able to inhibit the
dynamics of either actin filaments or microtubules, respectively.
These manipulations enabled the study of these two cytoskeletal
components to identify their specific interactions with LamR.
Taxol treatment inhibits tubulin dynamics through the hyperst-
abilization of microtubules. However, in our studies taxol
disrupted the microtubule structure, similarly to treatment with
nocodazole. The alteration in tubulin staining following taxol
treatment could have resulted from the extended incubation time
and was not the result of a loss in cell viability. In addition to the
disruption of the tubulin structure, taxol treatment dramatically
altered the localization of both S6 and LamR indicating that they
are bound to microtubules. Conversely, treatment of cells with CB
had no effect on LamR or S6 localization, indicating that neither
protein was associated with actin. These treatments were also used
in conjunction with
35S labeling to study the role of microfilaments
and microtubules in translation. These studies revealed that
treatment with taxol dramatically inhibits new protein synthesis.
Previous studies have indicated that taxol induces translational
arrest [56,57]. These studies confirm taxol-induced translational
arrest and indicate that not only is ribosomal association with
tubulin vital to translation, but also that a significant amount of
translation occurs at the cytoskeleton.
LamR plays an important role in attachment to the ECM. As a
cell surface receptor, LamR also plays a role in tumor invasion and
metastasis. Previous studies have shown co-localization of F-actin
with LamR within the cytoplasm of bovine vascular smooth
muscle cells [29]. Our in vitro binding studies showed a direct and
high affinity interaction between LamR and actin. Additionally,
our microscopy studies showed the reorganization of actin
filaments when cells are plated on laminin. We have also observed
the formation of lamellipodia in which LamR localized at the
termini of the actin fibers. Treatment with CB or transfection with
siLamR reveals that lamellipodia formation is induced by actin
filament reorganization, rather than LamR, since lamellipodia still
formed in siLamR transfected samples. Lamellipodia formation is
an important step in cell migration during which actin filament
reorganization is coupled with interactions with the ECM [53].
Our microscopy data examined the role of both LamR and actin
for efficient cell migration. We showed that CB treatment and
siLamR transfection independently reduced cell migration to
either 10% FCS or purified laminin by 80%, indicating that both
proteins are important for cell migration. Through other studies in
our lab aimed at characterizing the functions of LamR and its
interactions with laminin, it was determined that incubation of
cells with purified recombinant LamR can block their ability to
migrate toward laminin. Additionally, mutational analysis revealed
that the binding sites for actin and tubulin are separate from the
binding site of laminin [58]. These data underscore the
importance of LamR in cell migration.
We propose a model of interactions between LamR and the
cytoskeletal componentsactin and tubulin(Figure 6).LamR directly
interacts with both actin and tubulin, however, each interaction
appearstoservea differentpurpose.LamR interactionswithtubulin
are critical for cellular translation, where LamR acts as a molecular
tether linking the ribosomal components to tubulin (Figure 6A).
LamR interactions with actin are more complex. When cells are
Figure 5. LamR binds directly to components of the cytoskel-
eton. (A and B) LamR binds directly to the cytoskeleton as shown by an
in vitro ELISA assay whereby purified microtubules (A) or filamentous
actin (B) have been coated onto plates and the ability of purified
recombinant LamR to bind was assessed. Graphical representations of
the binding of either LamR (solid line) or ortholog, A. fulgidus S2p (RPS2)
(dashed line). LamR is able to bind directly to both tubulin and actin at a
significantly higher affinity than RPS2. Data in A and B represents the
SEM (error bars) of three experiments.
doi:10.1371/journal.pone.0015895.g005
The additional panel shown with the mock-treated sample represents a zoomed image of the area indicated by the white square. Following
treatment with CB, lamellipodia formation is inhibited, however, after knockdown of LamR these structures still form but LamR is not available to
localize to the actin fibers. Scale bars in A and B represent 10 mm. (C) Culturing cells on laminin-coated plates had no effect on localization or
concentration of LamR within the samples. Fractionation of cells plated on tissue culture coated or laminin coated plates. Samples were separated
into cytosolic (c), membrane (m) and nuclear (n) fractions. (D) Treatment with CB or ablation of LamR expression reduces cell migration. A graphical
representation of the ability of NIH 3T3 cells treated with CB or transfected with siLamR to migrate toward 10% FCS or laminin. CHX and serum
starved samples serve as controls for translation inhibition and cell cycle arrest respectively. Data in D represents the SEM (error bars) of three
experiments. Each sample was corrected for percent viability and was compared to the mock treated control. Statistical significance was calculated by
a two-tailed student t-test (* P,0.005).
doi:10.1371/journal.pone.0015895.g004
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does not co-localize with F-actin at the membrane (Figure 6A).
However, when cells are cultured on laminin-coated plates,
lamellipodia form and LamR is reorganized to the terminal ends
of the actin fibers (Figure 6B). The interaction between LamR and
actin is most likely important for the functions of LamR as a cell
surface receptor, specifically cell attachment and motility.
LamR is involved in numerous pathologies due to its role in
binding virus [8,9,10,59], prion proteins [11] and its overexpression
in cancer [12,13,14,15,16]. The expression of several other
ribosomal proteins is elevated in human cancers [60,61,62]
supporting the link between overexpression of LamR and cellular
transformation. LamR is involved in many processes that mediate
tumor aggressiveness including, cell migration [17], invasion [63]
and ECM remodeling [18]. The correlation between LamR
expression and tumor aggressiveness underscores the importance
of understanding LamR’s diverse functions. This study demon-
strates LamR’sabilityto directly bind tubulinand actin.Through its
interactionwithtubulin,LamRactsasamoleculartetherlinkingthe
ribosomalcomponents totubulinand mediating cellulartranslation.
The LamR-actin interaction is critical for cell migration, indicating
that this complex may be important to metastasis. These data
indicate that interactions between LamR and the cytoskeleton are
vital in mediating two processes that are intimately linked to cancer.
Study of the mechanisms of LamR and cytoskeletal interaction may
lead to the development of novel anti-cancer therapeutics.
Materials and Methods
Cell Lines and Treatments
NIH 3T3 cells were obtained from the American Type Culture
Collection. Cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) with 10% FCS supplemented with 100 mg/ml
of penicillin-streptomycin and 0.5 mg/ml amphotericin B (all from
Mediatech).
NIH 3T3 cells were treated with CB (Sigma) at a final
concentration of 5 mg/ml for 30 minutes at 37uC to disrupt the
actin filament structure. Cells were washed with phosphate
buffered saline (PBS) and used for downstream experiments. Cell
viability was assessed in parallel to each experiment (as described
below) following similar treatment and only samples greater than
80% viable were used.
NIH 3T3 cells were treated with Paclitaxel (taxol) (NovaPlus) at
a final concentration of 5 mM for 5 hours at 37uC to inhibit
microtubule dynamics. Cells were washed with PBS and used for
downstream experiments. Cell viability was assessed in parallel to
each experiment (as described below) following similar treatment
and only samples greater than 80% viable were used.
NIH 3T3 cells were treated with CHX (Sigma) at a final
concentration of 50 mg/ml for 5 hours at 37uC to inhibit cellular
translation. For downstream experiments cells were maintained in
CHX throughout. Cell viability was assessed in parallel (as
described below) following similar treatment and only samples
greater than 80% viable were used. For each experiment
inhibition of translation was confirmed using
35S labeling.
G1 phase cell cycle arrest was induced by incubating NIH 3T3
cells in serum free media for 24 hours at 37uC. Cell cycle arrest
was assessed through propidium iodide staining followed by
fluorescence activated cell sorting (FACS) analysis. Cell viability
was also assessed in parallel (as described below).
Immunofluorescence
NIH 3T3 cells were cultured on poly-D Lysine coated chamber
slides. Poly-D Lysine/laminin coated chamber slides were also
used as indicated (BD Bioscience). After CB or taxol treatment
described above or transfection with siRNA (as described below)
samples were processed for immunofluorescence. Briefly, cells
were washed with PBS, fixed with 4% paraformaldehyde and
permeabilized with 1% Triton X100. Cells were blocked at room
temperature with blocking buffer (0.1% Triton X100 containing
Figure 6. Model depicting the interactions of LamR with the cytoskeleton. (A) LamR’s interaction with tubulin is associated with cellular
translation. LamR tethers the ribosomal components to tubulin and translation can occur. When cells are plated on poly D-lysine, actin is localized to
the membrane and does not co-localize with LamR. (B) When cells are cultured on laminin-coated plates, actin reorganization is induced, resulting in
the formation of lamellipodia with LamR concentrated at the terminal ends. The LamR- actin interaction is most likely important for mediating the cell
surface functions of LamR, whereas the interaction with tubulin is integral to cellular translation.
doi:10.1371/journal.pone.0015895.g006
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anti-LamR H141 (1:200) (Santa Cruz), which recognizes amino
acids 110-250 of human LamR, to monitor intracellular
functions, used for co-staining in all a-tubulin experiments,
anti-LamR F18 (1:200) (Santa Cruz), which recognizes amino
acids 245-295 of human LamR, to study cell surface functions,
used for co-staining in all F-actin experiments, anti-a-Tubulin
(1:1000) (Cell Signaling Technologies) or anti-S6 (1:50) (Cell
Signaling Technologies) antibodies, all diluted in blocking buffer,
overnight at 4uC. Slides were washed with PBS and incubated
with Alexafluor 488 conjugated goat anti-mouse (1:500) (Molec-
ular Probes), Alexafluor 594 conjugated donkey anti-rabbit
(1:500) (Molecular Probes) secondary antibodies and Alexafluor
647 conjugated phalloidin (1:40), used for F-actin staining,
(Molecular Probes). Coverslips were mounted with Prolong Gold
Antifade Reagent (Invitrogen). For each experiment, samples
stained with secondary antibody alone were processed in parallel
to control for non-specific staining. Additionally, for all co-
localization studies, samples stained for localization of each
protein individually were processed in parallel and the fluores-
cence of adjacent channels was monitored for bleed through.
Samples were visualized with a confocal microscope (Axiovert
100m; Carl Zeiss MicroImaging, Inc.) fitted with a plan-
Apochroma 100/1.40 oil DIC objective lens. Images were
captured with a DKC-5000 digital camera (Sony) using the
LSM510 version 3.2 SP2 software (Carl Zeiss MicroImaging,
Inc.). Images were divided into individual channels for single
color visualization using Adobe Photoshop CS4.
Western Blotting
Cell lysates were collected using Mammalian Protein Extraction
Reagent (Pierce) supplemented with protease inhibitors (Roche)
according to the manufacturer’s instructions. Protein content was
measured using BioRad Dc Protein Reagent according to the
manufacturer’s instructions (BioRad). Lysates containing 25 mg
total protein were run on polyacrylamide gels (BioRad) under
reducing conditions. Protein was transferred to polyvinylidine
fluoride membrane (Millipore). Membranes were blocked with
non-fat dry milk and probed with anti-LamR H141 (1:2000)
(Santa Cruz), anti-S6 (1:1000) (Cell Signaling Technologies) or b-
actin (1:10,000) (Sigma) antibodies diluted in tris buffered saline,
0.05%Tween, 5% BSA. Proteins were detected using horseradish
peroxidase (HRP) conjugated secondary antibodies (Santa Cruz)
and then exposed by chemiluminescence (Pierce).
Short Interfering RNA Studies
To ablate expression of LamR or S6, cells were transfected with
siGENOME SMARTpool siRNA (Dharmacon). As a control, as
well as a measure of transfection efficiency, siGLO, a fluorescently
labeled RISC-free siRNA was used (Dharmacon). Briefly,
transfections were performed in 12 well plates with cells at 70%
confluency. Each oligo was used at a final concentration of
100 nmol/l. Oligos were incubated with Dharmafect reagent IV
(Dharmacon) for 15 minutes at room temperature. Then, 0.8 ml
of media was added and the mixture was added to the cells. After
24 hours cells were plated according to downstream experiments.
siGLO was used to calculate transfection efficiency through FACS
analysis. Only samples with greater than 80% transfection
efficiency were used. Efficient knockdown of LamR or S6 was
assessed through western blotting.
FACS Analysis
To assess transfection efficiency with siGLO, FACS analysis was
employed. Briefly, cells were trypsinized at 37uC and centrifuged
at 3006g for 5 minutes at 4uC. Samples were washed with PBS
and then resuspended in PBS: 4% paraformaldehyde (1:1) for
fixation. Samples were run on a FACSCaliber instrument (Becton
Dickinson). Data analysis was performed with FlowJo version 8.2
software (Tree Star, Inc.).
For cell cycle analysis following serum starvation cells were
trypsinized at 37uC and centrifuged at 3006 g for 5 minutes at
4uC. Samples were washed with PBS and resuspended in PBS. Ice
cold 100% ethanol was added dropwise and RNase was added at a
final concentration of 100 mg/ml. Samples were incubated
overnight at 4uC. Samples were then centrifuged at 3006 g for
5 minutes at 4uC and washed with PBS. Samples were
resuspended in PBS with the addition of propidium iodide at a
final concentration of 50 mg/ml. Samples were run on a FACScan
instrument (Becton Dickinson). Data analysis was performed with
ModFit LT v3.0 software (Verity Software House, Inc.).
35S Labeling
Following CB or taxol treatment, as described above, cells were
incubated with
35S methionine/cysteine (20 mCi/ml) (Perkin
Elmer) in methionine-free media for 2 hours at 37uC. Cells were
washed to remove unbound label and then incubated in DMEM
supplemented with 10% FCS for 30 minutes. Lysates were
collected with Mammalian Protein Extraction Reagent (Pierce)
and samples containing 20 mg of total protein were run on a 4–
15% gradient gel (BioRad). The gel was fixed in a solution of 50%
methanol and 10% acetic acid for 30 minutes with agitation. The
gel was then incubated with enhancer solution (GE Healthcare) for
10 minutes, dried for 2 hours at 80uC under vacuum and exposed
to film overnight at 280uC.
Assessment of Cell Viability
Cells were cultured on 96 well luminescence plates (BD
Bioscience). After initial treatment with CB, taxol, CHX, serum
starvation or siRNA transfection, cell viability was assayed with the
Cell Titer Glo assay (Promega). Briefly, Cell Titer Glo reagent was
added 1:1 directly to the cell culture media. Samples were
incubated at room temperature for 2 minutes with agitation and
then for an additional 10 minutes. After incubation luminescence
was read with a multiwell plate reader, Wallac EnVision (Perkin
Elmer). To calculate cell viability each sample was compared with
a similarly treated mock control.
Cell Fractionation
NIH 3T3 cells were cultured on tissue culture plates or laminin
coated plates (BD Bioscience). Cells were trypsinized, washed with
PBS and resuspended at 5610
6 cells/ml. Cells were subjected to
fractionation to separate cytosolic, membrane and nuclear
fractions using the Qproteome Cell Compartment Kit (Qiagen)
according to the manufacturer’s instructions. Successful fraction-
ation was confirmed by western blotting with markers specific to
each fraction.
Cell Migration Assay
Cells transfected with siRNA or untreated NIH 3T3 cells were
used for these assays. Transfected cells were harvested in the
optimal knockdown period, as confirmed by western blotting done
in parallel. Cell viability was also tested in parallel (as described
above). siRNA transfected, CHX, serum starved, CB or mock
treated cells were tested for their ability to migrate to either 10%
FCS or 15 mg/ml purified laminin (Invitrogen) using the
CytoSelect
TM 24-Well Cell Migration Assay (8 mm, Colorimetric
Format) (Cell Biolabs, Inc.). Briefly, 1.5610
5 cells in unsupple-
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well with the reservoir below containing 500 ml of either 10%
FCS, purified laminin or unsupplemented media (used to calculate
assay background). The plate was incubated at 37uC for 5 hours.
After the incubation was completed the upper membrane of each
insert was thoroughly washed with dH2O to remove non-
migratory cells. Inserts were then incubated in cell stain solution
for 10 minutes at room temperature, washed again in dH2O, and
allowed to dry. Inserts were then incubated with extraction
solution at room temperature for 10 minutes with gentle agitation.
100 ml of each sample was transferred to an ELISA plate and read
at 630 nm with the ELx800 plate reader (Biotek Instruments,
Inc.). To calculate migration ability, background was subtracted
and then each sample was corrected for cell viability and
compared to the similarly treated mock sample.
Protein Purification
Recombinant LamR was purified as described previously [64].
Briefly, a construct generated from human full length LamR was
transformed into E.coli strain BL21 (DE3*) and grown in Luria
broth to OD600 of 0.6 at 37uC. Protein expression was induced by
the addition of isopropyl-thiogalactopyranoside, 0.1 mM, at 20uC.
Cells were harvested and lysed by French press. The lysate was
cleared by centrifugation at 16,000 RPM for 30 minutes. The
supernatant was purified in two steps: by Ni-NTA chromatogra-
phy (Qiagen) followed by gel filtration chromatography (Superdex
75) (Amersham). A. fulgidus S2p (RPS2) (residues 1–208) was
expressed and purified under the same conditions.
Protein Binding ELISA
ELISA plates (Costar) were coated with 1.5 mg per well of either
filamentous actin or preformed microtubules (Cytoskeleton Inc.)
dissolved in coating buffer (0.1 M sodium bicarbonate pH 9.2)
overnight at 4uC. Plates were washed with wash buffer (PBS
containing 0.5% Tween). Plates were then incubated in blocking
buffer (2% FCS, 1 mg/ml BSA, 0.1% sodium azide in PBS) for
1 hour at 37uC. After incubation, plates were washed with wash
buffer, 3 times for 5 minutes each. Triplicate wells were incubated
with indicated concentrations of either purified LamR or A. fulgidus
S2p (RPS2) for 1 hour at 37uC. Plates were washed with wash
buffer. Wells were incubated with Penta-His HRP conjugate
(Qiagen) for 2 hours at room temperature. Plates were washed and
substrate solution was added. Absorbance at 490 nm was
measured on the ELx800 ELISA plate reader (Biotek Instruments,
Inc.) Each sample was normalized to background absorbance and
a binding curve was generated with Prism4.
Supporting Information
Figure S1 siRNA treatment controls. (A and B) Western
blot analysis of lysates collected from siLamR (A) or siS6 (B)
transfected NIH 3T3 cells illustrates efficient ablation of protein
expression. In A and B bactin was used as a loading control. (C)
35S labeling of siRNA transfected samples. Protein synthesis
remains unaffected in the siGLO-transfected, control sample. (D)
Transfection efficiency was monitored through transfection of
siGLO, a fluorescently labeled, RISC-free control oligo and
quantified by FACS analysis.
(TIF)
Figure S2 CHX and serum starvation treatment con-
trols. (A)
35S labeling of CHX treated NIH 3T3 cells. CHX
inhibited protein synthesis relative to the mock treated control. (B)
Cell cycle profile of mock and serum starved samples. Serum
starvation efficiently induced G1 phase cell cycle arrest.
(TIF)
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